Novogene America

Novogene America is a leading provider of genomic services and solutions based in the United States. Employing 383 people, the company boasts a $500 million annual revenue. Novogene specializes in next-generation sequencing (NGS) and bioinformatics services, offering unparalleled data quality to support research initiatives. Their expertise extends to Illumina platform services, as well as PacBio and Nanopore technologies. Novogene serves a diverse clientele of researchers and scientists from North and South America, including collaborations with institutions in the USA, Canada, Brazil, Colombia, and Mexico. The company is recognized as a world leader in NGS, holding 45 NGS-related patents and publishing over 950 scientific articles in prominent journals such as Cell, Nature, and Science, amassing a total impact factor exceeding 7,970. For inquiries and collaborations, please visit Novogene America's website at novogene.com/external.